Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference30 articles.
1. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators;Yusuf;N Engl J Med,2000
2. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heat failure: a combined analysis of three trials;Dagenais;Lancet,2006
3. Telmisartan, ramipril, or both in patients at high risk for vascular events;ONTARGET Investigators;N Engl J Med,2008
4. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomized controlled trial;TRANSCEND Investigators;Lancet,2008
5. Persistence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients;Mazzaglia;Circulation,2009
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease;Cochrane Database of Systematic Reviews;2024-04-29
2. A randomized trial of genotype-guided perindopril use;Journal of Hypertension;2023-08-17
3. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease;Cochrane Database of Systematic Reviews;2023-07-19
4. Medication Adherence and Blood Pressure Control Among Hypertensive Outpatients Attending a Tertiary Cardiovascular Hospital in Tanzania: A Cross-Sectional Study;Integrated Blood Pressure Control;2022-08
5. Genetic Variants Associated with Adverse Events after Angiotensin-Converting Enzyme Inhibitor Use: Replication after GWAS-Based Discovery;Yonsei Medical Journal;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3